Clinical trial
The Impact of Pneumococcal and Malaria Vaccines on Bacterial Resistance, Febrile Illness and Antibiotic Usage in Young Children in Malawi
NCT06450379 is registered in ClinicalTrials.gov with Malawi Liverpool Wellcome Programme as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Impact of Pneumococcal and Malaria Vaccines on Bacterial Resistance, Febrile Illness and Antibiotic Usage in Young Children in Malawi
- Lead sponsor
- Malawi Liverpool Wellcome Programme
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 15, 2021
- Completion date
- April 30, 2024
- Enrollment
- 13,200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
vaccine